Advertisement

Synthesis and biological evaluation of quercetin–zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells

  • Yu-Hsiang LeeEmail author
  • Pham-Thi Tuyet
Article
  • 14 Downloads

Abstract

Bladder cancer is the 13th leading cause of cancer death worldwide, and its mortality rate is highly associated with the motility of the malignant cells. Although the techniques of urothelial cancer treatment have been continuously advanced in the last decade, the invasive bladder cancer remains incurable and the mean survival time of the patients with high-grade malignancy after cancer relapse is still < 6 months, indicating a new strategy which can reduce bladder cancer cell motility and/or progression is urgently needed. Quercetin is a polyphenolic flavonoid with approved anti-tumor effect. However, the drawbacks of quercetin, including low absorption, extensive metabolism, and rapid elimination, severely hamper its availability in the clinic. In this study, we aim to synthesize the quercetin–zinc complex (Q-ZnCPX) and explore its anti-cancer and anti-metastasis efficacies on human bladder cancer cells in vitro. Based on the results of cell movement and protein expressions in BFTC-905 cells, we found that both cell migratability and invasiveness were markedly reduced by the Q-ZnCPX with concentration of ≥ 12.5 μM through p-AKT and MT1-MMP regulations compared to the cells without treatment (P < 0.05). Moreover, the synthesized Q-ZnCPX with ≥ 75 μM can even provide > 50% of mortality rate (P < 0.05) to the cancer cell after 24-h treatment. These results demonstrated that the synthetic Q-ZnCPX may serve as feasible tool for both anti-cancer and anti-metastasis on human bladder cancer cells dependent on the dosage.

Keywords

Quercetin–zinc complex Bladder cancer Anti-cancer Anti-metastasis 

Notes

Acknowledgments

This work was financially supported by the Ministry of Science and Technology, R.O.C. (MOST 107-2221-E-008-043; Y.-H. Lee).

Compliance with ethical standards

Conflict of interest

Yu-Hsiang Lee and Pham-Thi Tuyet declare that they have no conflict of interest.

References

  1. Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71:96–108CrossRefPubMedGoogle Scholar
  2. Bishayee K, Ghosh S, Mukherjee A, Sadhukhan R, Mondal J, Khuda-Bukhsh AR (2013) Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M, in cervical carcinoma: signal cascade and drug-DNA interaction. Cell Prolif 46:153–163CrossRefPubMedGoogle Scholar
  3. Bravo A, Anacona JR (2001) Metal complexes of the flavonoid quercetin: antibacterial properties. Transit Met Chem 26:20–23CrossRefGoogle Scholar
  4. Cornard JP, Merlin JC (2002) Spectroscopic and structural study of complexes of quercetin with Al (III). J Inorg Biochem 92:19–27CrossRefPubMedGoogle Scholar
  5. Costello LC, Feng P, Milon B, Tan M, Franklin RB (2004) Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 7:111–117CrossRefPubMedGoogle Scholar
  6. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9–34CrossRefPubMedGoogle Scholar
  7. Ezzati Nazhad Dolatabadi J, Mokhtarzadeh A, Ghareghoran SM, Dehghan G (2014) Synthesis, characterization and antioxidant property of quercetin-Tb(III) complex. Adv Pharm Bull 4:101–104PubMedGoogle Scholar
  8. Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M (2006) The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res 26:1177–1181PubMedGoogle Scholar
  9. Hong SH, Choi YS, Cho HJ, Lee JY, Hwang TK, Kim SW (2012) Induction of apoptosis of bladder cancer cells by zinc-citrate compound. Korean J Urol 53:800–806CrossRefPubMedGoogle Scholar
  10. Huang CY, Chan CY, Chou IT, Lien CH, Hung HC, Lee MF (2013) Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells. J Nutr Biochem 24:1596–1603CrossRefPubMedGoogle Scholar
  11. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMedGoogle Scholar
  12. Kalinowska M, Świderski G, Matejczyk M, Lewandowski W (2016) Spectroscopic, thermogravimetric and biological studies of Na(I), Ni(II) and Zn(II) complexes of quercetin. J Therm Anal Calorim 126:141–148CrossRefGoogle Scholar
  13. Kim HP, Mani I, Iversen L, Ziboh VA (1998) Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot Essent Fat Acids 58:17–24CrossRefGoogle Scholar
  14. Ko HS, Lee HJ, Kim SH, Lee EO (2012) Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: involvement of PI3K/AKT and NF-κB pathways. J Agric Food Chem 60:4083–4089CrossRefPubMedGoogle Scholar
  15. Lee KM, Hwang MK, Lee DE, Lee KW, Lee HJ (2010) Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J Agric Food Chem 58:5815–5820CrossRefPubMedGoogle Scholar
  16. Lee YH, Yeh CH (2018) Laminar shear stress inhibits high glucose-induced migration and invasion in human bladder cancer cells. In Vitro Cell Dev Biol Anim 54:120–128CrossRefPubMedGoogle Scholar
  17. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y (2016) Quercetin, inflammation and immunity. Nutrients 8:167CrossRefPubMedGoogle Scholar
  18. Lu CC, Yang JS, Chiang JH, Hour MJ, Amagaya S, Lu KW, Lin JP, Tang NY, Lee TH, Chung JG (2012) Inhibition of invasion and migration by newly synthesized quinazolinone MJ-29 in human oral cancer CAL 27 cells through suppression of MMP-2/9 expression and combined down-regulation of MAPK and AKT signaling. Anticancer Res 32:2895–2903PubMedGoogle Scholar
  19. MacDonald RS (2000) The role of zinc in growth and cell proliferation. J Nutr 130(5S Suppl):1500S–1508SCrossRefPubMedGoogle Scholar
  20. Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman AK, Miranda G, Gill IS, Daneshmand S (2012) Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int 109:846–854CrossRefPubMedGoogle Scholar
  21. Primikyri A, Mazzone G, Lekka C, Tzakos AG, Russo N, Gerothanassis IP (2015) Understanding zinc(II) chelation with quercetin and luteolin: a combined NMR and theoretical study. J Phys Chem B 119:83–95CrossRefPubMedGoogle Scholar
  22. Raza A, Xu X, Xia L, Xia C, Tang J, Ouyang Z (2016) Quercetin-iron complex: synthesis, characterization, antioxidant, DNA binding, DNA cleavage, and antibacterial activity studies. J Fluoresc 26:2023–2031CrossRefPubMedGoogle Scholar
  23. Shiomi T, Okada Y (2003) MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 22:145–152CrossRefPubMedGoogle Scholar
  24. Shirakawa R, Fukai S, Kawato M, Higashi T, Kondo H, Ikeda T, Nakayama E, Okawa K, Nureki O, Kimura T, Kita T, Horiuchi H (2009) Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPases. J Biol Chem 284:21580–21588CrossRefPubMedGoogle Scholar
  25. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30CrossRefPubMedGoogle Scholar
  26. de Souza RF, De Giovani WF (2004) Antioxidant properties of complexes of flavonoids with metal ions. Redox Rep 9:97–104CrossRefPubMedGoogle Scholar
  27. Tan J, Wang B, Zhu L (2009) DNA binding, cytotoxicity, apoptotic inducing activity, and molecular modeling study of quercetin zinc (II) complex. Bioorg Med Chem 17:614–620CrossRefPubMedGoogle Scholar
  28. Tu LY, Pi J, Jin H, Cai JY, Deng SP (2016) Synthesis, characterization and anticancer activity of kaempferol-zinc(II) complex. Bioorg Med Chem Lett 26:2730–2734CrossRefPubMedGoogle Scholar
  29. Valacca C, Tassone E, Mignatti P (2015) TIMP-2 interaction with MT1-MMP activates the AKT pathway and protects tumor cells from apoptosis. PLoS One 10:e0136797CrossRefPubMedGoogle Scholar
  30. Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S (2010) The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur J Pharmacol 649:84–91CrossRefPubMedGoogle Scholar
  31. Wang Z, Yang J, Fisher T, Xiao H, Jiang Y, Yang C (2012) Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells. Environ Health Perspect 120:92–97CrossRefPubMedGoogle Scholar
  32. Welf ES, Haugh JM (2011) Signaling pathways that control cell migration: models and analysis. Wiley Interdiscip Rev Syst Biol Med 3:231–2940CrossRefPubMedGoogle Scholar
  33. Weng CJ, Yen GC (2012) Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. Cancer Metastasis Rev 31:323–351CrossRefPubMedGoogle Scholar
  34. Woldu SL, Şanli Ö, Lotan Y (2017) Tackling non-muscle invasive bladder cancer in the clinic. Expert Rev Anticancer Ther 17:467–480CrossRefPubMedGoogle Scholar
  35. Wu Y, Moissoglu K, Wang H, Wang X, Frierson HF, Schwartz MA, Theodorescu D (2009) Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proc Natl Acad Sci U S A 106:5807–5812CrossRefPubMedGoogle Scholar
  36. Yang H, Guan L, Li S, Jiang Y, Xiong N, Li L, Wu C, Zeng H, Liu Y (2016) Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo. Oncotarget 7:16227–16247PubMedGoogle Scholar
  37. Yang S, Yin B, Xu L, Gao B, Sun H, Du L, Tang Y, Jiang W, Cao F (2015) A natural quercetin-based fluorescent sensor for highly sensitive and selective detection of copper ions. Anal Methods 7:4546–4551CrossRefGoogle Scholar
  38. Zhou R, Xu L, Ye M, Liao M, Du H, Chen H (2014) Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Horm Metab Res 46:753–760CrossRefPubMedGoogle Scholar

Copyright information

© The Society for In Vitro Biology 2019

Authors and Affiliations

  1. 1.Department of Biomedical Sciences and EngineeringNational Central UniversityTaoyuan CityTaiwan, Republic of China
  2. 2.Department of Chemical and Materials EngineeringNational Central UniversityTaoyuan CityTaiwan, Republic of China

Personalised recommendations